Canadian Deputy Prime Minister Christia Freeland said that we have a responsibility to ensure Coronavirus disease Not only are they cancelled within our own borders, they are also cancelled abroad.
Her comments were made after the G20 meeting in Venice, when the leaders of the 20 most powerful economies in the world agreed that due to the emergence of new COVID-19 variants, the global economic recovery is at risk-this risk is for some countries Of poor people exacerbated Get a vaccine.
“We are focused on doing everything necessary to ensure the safety of Canadians and ensure that Canadians are vaccinated. I really want to congratulate Canadians because we have seen our country’s enthusiasm for vaccination abroad so high,” Freeh Lan told reporters on a conference call on Saturday.
“Nevertheless, we also absolutely recognize that this is a global pandemic, and we have a practical and moral responsibility to fight this pandemic worldwide.”
In Canada, more than 78% of the population has at least one dose of the COVID-19 vaccine. As of Saturday, another 48% have been fully vaccinated. According to the Canadian COVID-19 tracker.
These figures are in stark contrast to the vaccination rates of many other countries in the world-some countries have first dose coverage as low as 1%.
Dr. Peter Singer, a WHO consultant, said in an interview: “In some parts of the world, even if one dose of vaccine is given, the vaccination rate is only 1%, 2%, 3%, 5%.” and Global News.
“For safety, fire anywhere in the world is extinguished, otherwise, if it burns anywhere, it will release embers, and embers will ignite flames anywhere.”
Singh is not alone.
Infectious disease experts have issued a similar warning, pointing out that helping other countries is not an act of selflessness—it is actually protecting everyone.
“When (COVID) burns in other places, it is really leaving by plane. Therefore, this may also lead to an outbreak here,” Dr. Sumon Chakrabarti said.
“Providing vaccines for everyone around the world will benefit all of us.”
Experts say that in addition to helping save lives abroad, responding to COVID-19 will also help keep the world ahead of one of the biggest risk factors of a pandemic-variants.
As the virus spreads, it will replicate. With every opportunity that a virus must replicate, it has more and more opportunities to make mistakes. Sometimes these mistakes ultimately benefit the virus-either make it easier to spread, or it may make the virus worse.
The more COVID-19 spreads, the more opportunities it has to replicate and mutate. Infectious disease expert Dr. Zain Chagla explained to Global News that this means that the biggest risk of mutation is that uncontrolled transmission is still occurring in large areas of the world.
“The main factor leading to variation is the large number of unvaccinated people, especially those with very poor health systems and patients with immune system diseases,” he said.
Freeland said on Saturday that Canada has taken steps to try to help strengthen vaccination efforts around the world.
The government has donated US$1.3 billion to the World Health Organization’s ACT accelerator, which aims to establish a framework involving governments, philanthropists, and civil society (to name a few) to work together to help ensure the smooth progress of global vaccination efforts.
Prime Minister Justin Trudeau also pledged to contribute 100 million doses of vaccine to the global vaccination effort at the G7 meeting in June.
However, after Pfizer recently announced plans to create a new vaccine designed to fight the Delta variant of COVID-19, experts began to pay attention to the world’s vaccine priorities. If approved, this may be the third injection that some people have received, and some countries are still waiting for their first batch of vaccines.
John Moore, a virologist at Weill Cornell College of Medicine in New York, told Global News: “For Americans, there are ethical issues to prioritize the third dose over the first and second doses in other parts of the world.”
“The general feeling is that now is not the right time for the third dose of mRNA vaccine.”
Insufficient global vaccine supply may produce COVID-19 mutation, and economic recovery risks: G20
Although few studies have shown how long the protection provided by the COVID-19 vaccine can last, early studies are promising.
A study Published in the journal Nature In late June, it was discovered that mRNA-based vaccines produce a more “persistent” germinal center B cell response, which means that a person’s immune response to the jab is stronger and longer lasting.
The researchers examined the participants four months after receiving the first dose of Pfizer and found that the germinal centers in their lymph nodes are like boot camps for immune cells, constantly secreting the cells needed to fight COVID-19.
This has led some people to question Pfizer’s motives for pursuing new boosters.
“Someone (says) Pfizer is a bit opportunistic,” Moore said.
“The idea of promoting vaccine boosters will of course greatly increase vaccine sales.”
Although Pfizer supports its latest research plan, claiming that “mutations are expected to continue,” experts say that the lack of global vaccine coverage is still a greater threat in terms of lethal mutations in the virus.
Chagla said: “We can make vaccines to make ourselves more resistant to the evolution of this virus.”
“But if we don’t solve the root cause of this virus evolution, then we will chase our tails over and over again.”
© 2021 Global News, a division of Corus Entertainment Inc.
